These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15654072)
21. [The antigonadrotropic activity of chlormadinone acetate in reproductive women]. Chassard D; Schatz B Gynecol Obstet Fertil; 2005; 33(1-2):29-34. PubMed ID: 15752663 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
23. The combined oral contraceptive pill and the assumed 28-day cycle. Dowse MS; Gunby A; Moncad R; Fife C; Smerdon G; Bryson P J Obstet Gynaecol; 2007 Jul; 27(5):481-4. PubMed ID: 17701795 [TBL] [Abstract][Full Text] [Related]
24. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052 [TBL] [Abstract][Full Text] [Related]
25. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle. Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Messinis IE Clin Endocrinol (Oxf); 2009 Sep; 71(3):383-7. PubMed ID: 19094072 [TBL] [Abstract][Full Text] [Related]
26. Influence of gender and menstrual cycle on volatile sulphur compounds production. Calil CM; Lima PO; Bernardes CF; Groppo FC; Bado F; Marcondes FK Arch Oral Biol; 2008 Dec; 53(12):1107-12. PubMed ID: 18691697 [TBL] [Abstract][Full Text] [Related]
27. Fluctuations in carotid arterial distensibility during the menstrual cycle do not influence cardiovagal baroreflex sensitivity. Hayashi K; Miyachi M; Seno N; Takahashi K; Yamazaki K; Sugawara J; Yokoi T; Onodera S; Mesaki N Acta Physiol (Oxf); 2006 Feb; 186(2):103-10. PubMed ID: 16497187 [TBL] [Abstract][Full Text] [Related]
28. Some psychological correlates of motion sickness susceptibility. Collins WE; Lentz JM Aviat Space Environ Med; 1977 Jul; 48(7):587-94. PubMed ID: 883927 [TBL] [Abstract][Full Text] [Related]
29. How to improve noninvasive coronary artery disease diagnostics in premenopausal women? The influence of menstrual cycle on ST depression, left ventricle contractility, and chest pain observed during exercise echocardiography in women with angina and normal coronary angiogram. Grzybowski A; Puchalski W; Zieba B; Gruchala M; Fijalkowski M; Storoniak K; Sobiczewski W; Ciecwierz D; Targonski R; Rynkiewicz A Am Heart J; 2008 Nov; 156(5):964.e1-964.e5. PubMed ID: 19061713 [TBL] [Abstract][Full Text] [Related]
30. Oral contraceptive pill use and abnormal menstrual cycles in women with severe condylar resorption: a case for low serum 17beta-estradiol as a major factor in progressive condylar resorption. Gunson MJ; Arnett GW; Formby B; Falzone C; Mathur R; Alexander C Am J Orthod Dentofacial Orthop; 2009 Dec; 136(6):772-9. PubMed ID: 19962599 [TBL] [Abstract][Full Text] [Related]
31. Phenylthiocarbamide taste perception and susceptibility to motion sickness: linking higher susceptibility with higher phenylthiocarbamide taste acuity. Sharma K; Sharma P; Sharma A; Singh G J Laryngol Otol; 2008 Oct; 122(10):1064-73. PubMed ID: 18252010 [TBL] [Abstract][Full Text] [Related]
32. Sex differences in tolerance to visually-induced motion sickness. Flanagan MB; May JG; Dobie TG Aviat Space Environ Med; 2005 Jul; 76(7):642-6. PubMed ID: 16018346 [TBL] [Abstract][Full Text] [Related]
34. Motion sickness susceptibility fluctuates through the menstrual cycle. Golding JF; Kadzere P; Gresty MA Aviat Space Environ Med; 2005 Oct; 76(10):970-3. PubMed ID: 16235881 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of divers in open water to motion sickness. Norfleet WT; Peterson RE; Hamilton RW; Olstad CS Undersea Biomed Res; 1992 Jan; 19(1):41-7. PubMed ID: 1536062 [TBL] [Abstract][Full Text] [Related]
36. Seasickness susceptibility, personality factors, and salivation. Gordon CR; Ben-Aryeh H; Spitzer O; Doweck I; Gonen A; Melamed Y; Shupak A Aviat Space Environ Med; 1994 Jul; 65(7):610-4. PubMed ID: 7945127 [TBL] [Abstract][Full Text] [Related]
37. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma. Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397 [TBL] [Abstract][Full Text] [Related]
38. Weight change and ovarian steroid profiles in young women. Chapman JF; McIntyre MH; Lipson SF; Ellison PT Fertil Steril; 2009 Mar; 91(3):858-61. PubMed ID: 18314121 [TBL] [Abstract][Full Text] [Related]
39. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Barbosa IC; Filho CI; Faggion D; Baracat EC Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291 [TBL] [Abstract][Full Text] [Related]
40. High dose ondansetron for reducing motion sickness in highly susceptible subjects. Muth ER; Elkins AN Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]